Tag Archives: Michael Schill

RIP (rest in peace) Sir Fraser Stoddart, nanotechnology pioneer

I received (via email and it’s also here) a January 2, 2025 Northwestern University news release by Megan Fellman announcing Sir Fraser Stoddart’s (also known as, J. Fraser Stoddart) death on December 30, 2024, Note: Links have been removed,

Sir Fraser Stoddart, a pioneer in nanoscience, dies at 82

Stoddart received the 2016 Nobel Prize in Chemistry for work on molecular machines

EVANSTON, Ill. — Nobel laureate Sir Fraser Stoddart, a Board of Trustees Professor at Northwestern University, died Dec. 30 [2024]. He was 82.

Stoddart, a pioneer in the fields of nanoscience and organic chemistry, was an outsized figure on the Evanston campus and on campuses he visited around the globe. By introducing an additional type of bond — the mechanical bond — into chemical compounds, Stoddart became one of the
few chemists to have opened a new field of chemistry during the past 30 years.

His work on molecular recognition and self-assembly and his subsequent introduction of template-directed routes to mechanically interlocked molecules dramatically changed the way chemists make soft materials.

Throughout his long career of research and teaching, Stoddart mentored a diverse group of more than 500 graduate and postdoctoral students from around the world. Gregarious and thoughtful, he particularly cherished this work and the resulting relationships, many of them lifelong.

“Fraser was a giant in fields of nanoscience and organic chemistry, but his influence was equally impressive in the classrooms and labs on our campus,” said Northwestern President Michael Schill. “He was incredibly generous with his time and mentored so many students and
faculty, helping pave important new paths of inquiry and discovery. His impact on our university — and the world — was enormous.”

Omar Faha, the Charles E. and Emma H. Morrison Professor in Chemistry at Northwestern and chair of the department, said beyond his scientific brilliance, Stoddart was a steadfast friend and mentor, always generous with his time, wisdom and encouragement. “His contributions to our community went far beyond his accolades, as he supported and elevated each of us through his boundless energy and spirit.”

Since 2023, Stoddart was the Chair Professor of Chemistry at the University of Hong Kong.

A Northwestern Nobel

Stoddart received the Nobel Prize in Chemistry in 2016, along with Jean-Pierre Sauvage and Bernard L. Feringa, “for the design and synthesis of molecular machines.” The Royal Swedish Academy of Sciences credited them with developing “molecules with controllable movements, which can perform a task when energy is added.”

“The development of computing demonstrates how the miniaturization of technology can lead to a revolution,” the academy said in its announcement. “The 2016 Nobel Laureates in Chemistry have miniaturized machines and taken chemistry to a new dimension.”

For his part, Stoddart was awarded the prize because, the academy said, in 1991 he developed a rotaxane. He threaded a molecular ring onto a thin molecular axle and demonstrated that the ring was able to move along the axle. Among his developments based on rotaxanes are a molecular lift, a molecular muscle and a molecule-based computer chip.

Stoddart’s introduction of the mechanical bond, which has led to the fabrication of artificial molecular switches and motors, has been responsible for putting chemists at the forefront of the burgeoning field of molecular nanotechnology, with implications ranging all the way from information technology to health care.

Upon becoming the second Nobel Prize winner from Northwestern’s department of chemistry, Stoddart expressed his appreciation for the University’s academic community.

“I also share this recognition with my students, postdoctoral fellows and colleagues,” he said. “Northwestern is a special place, where everyone does science in a collaborative way. It happens seamlessly here. If you don’t have the expertise, you can find it, and people step forward without being asked. It is well known that we hunt in packs at Northwestern.”

Said Adrian Randolph, dean of the Weinberg College of Arts and Sciences at Northwestern: “Sir Fraser brought a sparkling creativity, an indefatigable work ethic, a global perspective and a sharp wit that often reflected his broad interests and his belief in the value of a liberal arts education to his work and life. His scientific findings and ambition will continue to reverberate through the College and University. He will be sorely missed.”

Scientific achievements

Stoddart’s achievements include raising the bar for molecular electronics. For example, he used molecules on the nanoscale as the tiniest of switches, which have been incorporated into the densest of memory chips in a device that can hold the Declaration of Independence but is only the size of a white blood cell. He also gave practical expression to artificial molecular switches using nanovalves planted on the surfaces of mesoporous glass nanoparticles to create controllable and targeted drug delivery systems for the treatment of cancer and other degenerative diseases.

In 2007, The Sunday Times in the U.K. wrote that Stoddart “is to nanotechnology what J.K. Rowling is to children’s literature.”

That same year, he was appointed by Her Majesty Queen Elizabeth II as a Knight Bachelor in her 2007 New Year’s Honours List for his services to “Chemistry and Molecular Nanotechnology.”

“After being knighted, the queen and I had a short exchange, and I concluded she had her wits about her and had done her homework,” Stoddart recalled in a 2022 interview with Northwestern Now after the Queen’s passing. He was one of three to receive knighthoods at a ceremony that included other significant honors. “The main subject of conversation among us afterwards was, ‘How did she know so much about me?’”

A native of Edinburgh, Scotland, Stoddart also received the Royal Medal in 2010 from His Royal Highness the Duke of Edinburgh at the Royal Society of Edinburgh (RSE), Scotland’s national academy of arts and sciences.

A common theme of Stoddart’s research was the quest for a better fundamental understanding of self-assembly and molecular recognition processes in chemical systems. He worked for more than three decades on using this growing understanding to develop template-directed protocols that rely upon such processes to create artificial molecular machines. Stoddart’s philosophy of transferring concepts from biology into chemistry was behind his bottom-up approach to the construction of integrated nanosystems.

“My research on mechanically interlocked molecules, which has taken the field of supramolecular chemistry, i.e., chemistry beyond the molecule, back into the molecular domain, heralds a game-changer for molecular nanotechnology,” Stoddart once said.

Northwestern nanoscientist Chad Mirkin said hiring Stoddart was one of the best moves the University made.

“He is a big part of the ‘rise of Northwestern’ story,” said Mirkin, the George B. Rathmann Professor of Chemistry and a professor of medicine, chemical and biological engineering, biomedical engineering, and materials science and engineering. “Generous with his time, intellect and support, he made Northwestern and everyone around him better.”

Other honors and activities

Stoddart was elected to Fellowship of the American Academy of Arts and Sciences in 2012, membership of the National Academy of Sciences in 2014, foreign membership of the Chinese Academy of Sciences in 2017 and Fellowship of the National Academy of Inventors in 2019.

During his career, Stoddart received many other prestigious national and international awards and honors. They include being elected an Honorary Fellow of both the RSE and the Royal Society of Chemistry (RSC) and receiving the Davy Medal from the Royal Society of London, the national
academy of science of the United Kingdom and the Commonwealth, of which he was also a Fellow. Other awards include the China International Science and Technology Cooperation Award, the Nagoya Gold Medal in Organic Chemistry, the American Chemical Society’s Arthur C. Cope Award, the Feynman Prize in Nanotechnology, the King Faisal International Prize in Science, the Tetrahedron Prize for Creativity in Organic Chemistry, the Albert Einstein World Award of Science and the RSC’s Centenary Prize.

Stoddart served on the international advisory boards of numerous journals, including Chemistry World, Organic Letters and ChemPlusChem. He published more than 1,300 scientific papers and trained more than 500 graduate and postdoctoral students during an academic career that spanned five decades.

Northwestern professor Will Dichtel was one of Stoddart’s postdoctoral researchers.

“Underlying his considerable accolades was an endlessly supportive and caring mentor, colleague and friend. I was fortunate to learn from him first as a postdoctoral researcher at UCLA, just before he moved to Northwestern, where he encouraged my creativity and courage to tackle big scientific problems,” said Dichtel, the Robert L. Letsinger Professor of Chemistry.

“Later, in my independent career, he continued to support, encourage and challenge me. Fraser played this role to hundreds of scientists around the world. We will all miss him dearly and take this sad occasion to reflect upon and acknowledge his considerable personal and scientific
impact.”

Prior to Northwestern

Before joining the Northwestern faculty, Stoddart was Fred Kavli Chair in Nanosystems Sciences at the University of California at Los Angeles and director of the California NanoSystems Institute. He came to UCLA in 1997 from England’s University of Birmingham, where he had been a professor of organic chemistry since 1990 and had headed the university’s School of Chemistry since 1993.

Born in Edinburgh in 1942, Stoddart received his Bachelor of Science (1964), Ph.D. (1966) and D.Sc. (1980) degrees from the University of Edinburgh.

In 1967, he moved to Queen’s University in Ontario, Canada, where he was a National Research Council postdoctoral fellow and then, in 1970, to England’s University of Sheffield, where he was first an Imperial Chemical Industries (ICI) research fellow before becoming a faculty lecturer (assistant professor) in chemistry. After spending a three-year “secondment” (1978 to 1981) at the ICI Corporate Laboratory in Runcorn, England, he returned full time to the University of Sheffield,
where he was promoted to a readership (associate professorship). He moved to the University of Birmingham in 1990 to take up the Chair of Organic Chemistry.

Survivors include his two daughters, Fiona McCubbin of Belmont, Massachusetts, and Alison Stoddart of Cambridge, UK, and five grandchildren. His wife, Norma, preceded him in death.

I have an October 6, 2016 post for when the 2016 Nobel Prize in Chemistry was announced but I find a February 19, 2018 posting “2016 Nobel prize winner introduces anti-aging skincare line” about Stoddart’s then latest venture more intriguing.

2024 Kavli Prize Laureates: in the fields of astrophysics, nanoscience and neuroscience

The Kavli Prize has yet to acquire the lustre of a Nobel Prize (first awarded in 1901 as per its Wikipedia entry). By comparison the Kavli Prize is relatively new (established in 2005 as per its Wikipedia entry) but it appears to be achieving big deal status in the US.

This year’s crop of prize winners was listed in a June 12, 2024 Kavli Foundation news release on EurekAlert,

Eight scientists from three countries are honored for their research that has broadened our understanding of the big, the small and the complex.

June 12, 2024 (Oslo, Norway) — The Norwegian Academy of Science and Letters today announced the 2024 Kavli Prize Laureates in the fields of astrophysics, nanoscience and neuroscience. Eight scientists from three countries are honored for their research that has broadened our understanding of the big, the small and the complex. The laureates in each field will share $1 million USD. 

The 2024 Kavli Prizes recognize groundbreaking science for the discovery and characterization of extra-solar planets and their atmospheres; foundational research integrating synthetic nanoscale materials for biomedical use; and the localization of areas in the brain specialized for face recognition and processing.  

The 2024 Kavli Prize Laureates are:  

  • Kavli Prize in Astrophysics: David Charbonneau (Canada/USA) and Sara Seager (Canada/USA) 
  • Kavli Prize in Nanoscience: Robert S. Langer (USA), Armand Paul Alivisatos (USA) and Chad A. Mirkin (USA) 
  • Kavli Prize in Neuroscience: Nancy Kanwisher (USA), Winrich Freiwald (Germany), and Doris Tsao (USA) 

“The Kavli Prize 2024 honors outstanding researchers doing fundamental science that moves the world forward. They are exploring planets outside our solar system; they have broadened the scientific field of nanoscience towards biomedicine; and they are adding to our understanding of the neurological basis of face recognition,” said Lise Øvreås, president at The Norwegian Academy of Science and Letters.  

Astrophysics: Searching for life beyond Earth  

The 2024 Kavli Prize in Astrophysics honors Sara Seager and David Charbonneau for discoveries of exoplanets and the characterization of their atmospheres. They pioneered methods for the detection of atomic species in planetary atmospheres and the measurement of their thermal infrared emission, setting the stage for finding the molecular fingerprints of atmospheres around both giant and rocky planets. Their contributions have been key to the enormous progress seen in the last 20 years in the exploration of myriad exo-planets.  

“Humans have always looked towards the stars for discoveries. The pivotal research conducted by Seager and Charbonneau has been an important first step towards finding new planets and strong evidence of life elsewhere in the universe,” remarked Viggo Hansteen, Chair of the Astrophysics Committee.  

David Charbonneau led the team that used the transit method to discover a giant exoplanet (HD 209458b). He pioneered the application of space-based observatories to perform the first studies of the atmosphere of giant extrasolar planets. This new method measures the tiny amount of light blocked by such a planet as it passes in front of its host star. Charbonneau has also used the transit method to study exoplanetary atmospheres, measuring molecular spectra using both filtered starlight and infrared emission from the planets themselves. He demonstrated these two approaches with observations from the Hubble Space Telescope in 2002 and the Spitzer Space Telescope three years later.  

Sara Seager pioneered the theoretical study of planetary atmospheres and predicted the presence of atomic and molecular species detectable by transit spectroscopy, most notably the alkali gases. She predicted how transits could be used to measure atomic and molecular characteristics in exoplanetary atmospheres, which is crucial for identifying biomarkers – signs of life. Seager made outstanding contributions to the understanding of planets with masses below that of Neptune. She also carried out extensive research on starshades – enormous petal-like structures designed to shield space observatories from the glare of a faraway Sun-like star – and was among the first to recognize their importance in detecting and characterizing the faint light from any Earth-like planet orbiting the star. 

Nanoscience: Integrating nanomaterials for biomedical advances 

The 2024 Kavli Prize in Nanoscience honors Robert S. Langer, Armand Paul Alivisatos and Chad A. Mirkin who each revolutionized the field of nanomedicine by demonstrating how engineering nanoscale materials can advance biomedical research and application. Their discoveries contributed foundationally to the development of therapeutics, vaccines, bioimaging and diagnostics.   

“The three scientists, Langer, Alivisatos and Mirkin, have broadened the scientific field of nanoscience, building from fundamental research. By scientific curiosity they have become inventors for the future of nanoscience and biomedicine,” stated Bodil Holst, Chair of the Nanoscience Committee.  

Robert S. Langer was the first to develop nano-engineered materials that enabled the controlled release, or regular flow, of drug molecules. This capability has had an immense impact for the treatment of a range of diseases, such as aggressive brain cancer, prostate cancer and schizophrenia. His work also showed that tiny particles, containing protein antigens, can be used in vaccination, and was instrumental in the development of the delivery of mRNA vaccines. 

Armand Paul Alivisatos demonstrated that semiconductor nanocrystals, or quantum dots (nanoparticles that possess bright, size-dependent light-emitting properties), can be used as multicolor probes in bioimaging. Essential to this achievement was the synthesis of biocompatible nanocrystals. Semiconductor nanocrystals became the basis for the widely used research and diagnostic tools such as live cell tracking, labelling and in vivo imaging. 

Chad A. Mirkin engineered spherical nucleic acids (SNA) using a gold nanoparticle as the core, and a cloud of radially distributed DNA or RNA strands as the shell. He was then able to show how SNAs can be combined to create larger structures and how they can be used in biodiagnostics. His discovery led to the development of fast, automated point-of-care medical diagnostic systems.  

Neuroscience: Understanding recognition of faces 

The 2024 Kavli Prize in Neuroscience honors Nancy Kanwisher, Doris Tsao and Winrich Freiwald for the discovery of a specialized system within the brain to recognize faces. Their discoveries have provided basic principles of neural organization and made the starting point for further research on how the processing of visual information is integrated with other cognitive functions.  

“Kanwisher, Freiwald and Tsao together discovered a localized and specialized neocortical system for face recognition. Their outstanding research will ultimately further our understanding of recognition not only of faces, but objects and scenes,” commented Kristine Walhovd, Chair of the Neuroscience Committee.  

Nancy Kanwisher was the first to prove that a specific area in the human neocortex is dedicated to recognizing faces, now called the fusiform face area. Using functional magnetic resonance imaging (fMRI) she found individual differences in the location of this area and devised an analysis technique to effectively localize specialized functional regions in the brain. This technique is now widely used and applied to domains beyond the face recognition system.  

Elaborating on Kanwisher’s findings, Winrich Freiwald and Doris Tsao studied macaques and mapped out six distinct brain regions, known as the face patch system, including these regions’ functional specialization and how they are connected. By recording the activity of individual brain cells, they revealed how cells in some face patches specialize in faces with particular views.  

Tsao proceeded to identify how the face patches work together to identify a face, through a specific code that enables single cells to identify faces by assembling information of facial features. For example, some cells respond to the presence of hair, others to the distance between the eyes. 

Freiwald uncovered that a separate brain region, called the temporal pole, accelerates our recognition of familiar faces, and that some cells are selectively responsive to familiar faces. 

There’s a video of the official 2024 Kavli Prize announcement which despite the Kavli Foundation being headquartered in California, US, was held (as noted in the news release) at the Norwegian Academy of Science and Letters where the organization’s president, Lise Øvreås, revealed the 2024 Kavli Prize laureates..(I’ll get back to that choice of location.)

The 2024 Kavli Prize in Nanoscience

There are many posts here featuring work from Robert S. Langer (or Robert Langer), Armand Paul Alivisatos (or Paul Alivisatos or A. Paul Alivisatos) and Chad A. Mirkin (or Chad Mirkin).

Northwestern University (Chicago, Illinois) issued a June 12, 2024 news release (also received via email) by Maria Paul that provides a few more details about the nanoscience winners (main focus: Chad Mirkin), the prize, and the Kavli Foundation. Note: A link has been removed,

Northwestern University nanoscientist Chad Mirkin has been awarded The 2024 Kavli Prize in Nanoscience by The Norwegian Academy of Science and Letters. Mirkin is the first Northwestern scientist to receive the prestigious award.

Mirkin is recognized for his discovery of spherical nucleic acids (SNAs), nanostructures comprised of a nanoparticle core and a shell of radially distributed DNA or RNA strands. These globular forms of nucleic acids have become the cornerstones of the burgeoning fields of nanomedicine and colloidal crystal engineering with DNA. They allow scientists to construct new forms of matter using particle “atoms” as the basic building blocks and DNA “bonds” as particle interconnects, and they are the basis for powerful tools that allow researchers and clinicians to track and treat disease in new ways. In particular, SNAs have led to the development of fast, automated point-of-care medical diagnostic systems and new experimental drugs for treating many forms of cancer, neurological disorders, and diseases of the skin.

Mirkin is one of three laureates in nanoscience recognized by The Norwegian Academy for revolutionizing the field of nanomedicine by demonstrating how engineering nanoscale structures can advance biomedical research and application. The other two are Robert Langer of the Massachusetts Institute of Technology and Paul Alivisatos of the University of Chicago [emphasis mine]. The scientists’ discoveries “contributed foundationally to the development of therapeutics, vaccines, bioimaging and diagnostics,” The Norwegian Academy said in a release. They will share the $1 million award.

“When I first found out I won The Kavli Prize, there was both excitement but also relief, because I consider Northwestern to be the ultimate center for nanotechnology research,” Mirkin said. “To be recognized with this award, along with my incredible co-awardees, was great validation of what we’ve been trying to do at Northwestern. While I’m proud of what we’ve accomplished, the best is yet to come.”

The laureates will be awarded the prize on Sept. 3 during a ceremony in Oslo, Norway, presided over the by The Royal Family. The Kavli Prizes thus far have honored 65 scientists from 13 countries. Ten laureates received the Nobel Prize after receiving The Kavli Prize. [emphasis mine]

“I am thrilled for Chad, for the International Institute for Nanotechnology and for Northwestern,” Northwestern President Michael Schill said. “Chad has earned this prestigious and influential award in a pathbreaking area of science that is aligned with two of the University’s key priorities — to lead in decarbonization, renewable energy and sustainability, and innovating in the biosciences to help prolong lives and make the world a healthier place.

“Through groundbreaking research and hard work, Chad and his team have made Northwestern a leading center for nanotechnology research and investment. The fact that he is sharing this award with President Alivisatos at U of C further emphasizes how the Chicago area has become an international hub for nano research.”

The vision for The Kavli Prize comes from Fred Kavli, a Norwegian-American entrepreneur and philanthropist [emphasis mine] who turned his lifelong fascination with science into a lasting legacy for recognizing scientific breakthroughs and supporting basic research.

Since the first awards in 2008, The Kavli Prize has recognized innovative scientific research — from the discovery of CRISPR-Cas9 to the detection of gravitational waves — transforming our understanding of the big, the small and the complex.

Mirkin’s discovery of SNAs has far-reaching implications for biology and medicine. SNAs, which have no known natural equivalents, interact uniquely with living systems compared to nucleic acids of other forms. Mirkin was the first to synthesize SNAs and elucidate the distinctive chemical and physical properties that underpin their use in transformative techniques and technologies in medicine and the life sciences. This work has led to the development of the first commercialized molecular medical diagnostic systems of the modern nanotechnology era, such as the Food and Drug Administration-cleared Verigene System, used in over half of the world’s top hospitals to detect diseases with high sensitivity and selectivity.

Illinois Gov. JB Pritzker praised Mirkin for his extraordinary contributions to the field of nanotechnology and how his innovations have helped find solutions to some of society’s biggest challenges.

“Academic institutions in Chicago and across Illinois have become the biggest drivers in nanoscience and technology over the last three decades,” Pritzker said. “Chad Mirkin and his Northwestern colleagues have made outstanding scientific discoveries that change how we view the world around us.”

In 1996, Mirkin created the first SNAs with DNA shells on gold nanoparticle cores. Over the years, he has developed numerous other types of SNAs with other shells and cores, including proteins, liposomes and FDA-approved materials, as well as core-less, hollow structures composed entirely of nucleic acids. These cores impart unique properties to the SNAs, such as optical and magnetic characteristics, while also serving as scaffolds to densely arrange the oligonucleotides, which participate in binding. This dense arrangement gives rise to the novel functional properties that differentiate SNAs from the natural linear and two-dimensional nucleic acids and make them particularly effective in interacting with certain biological structures within cells and tissues. SNAs, unlike conventional DNA and RNA, are naturally taken up by cells without the need for toxic, positively charged co-carriers, making them highly effective in RNA interference (RNAi), antisense gene regulation, and gene editing pathways.

Mirkin’s pioneering work on SNAs has also advanced the development of immunotherapeutics, structures capable of stimulating a patient’s immune response to fight both infectious diseases and certain forms of cancer. Using SNAs, Mirkin has pioneered the concept of rational vaccinology, where he demonstrated that the structure of a vaccine, rather than the components alone, is crucial for dictating its therapeutic effectiveness. This insight and these “structural nanomedicines” have opened new possibilities for developing curative treatments by rearranging known components into more effective structures at the nanoscale. Mirkin founded Flashpoint Therapeutics to commercialize these innovations, focusing on nucleic acid-based nanostructure cancer vaccines. Mirkin also invented the first SNA-based antiviral vaccine, using COVID-19 as a model. These SNAs, featuring the spike protein’s RBD subunit in the core, achieved a 100% survival rate in humanized mice challenged with the live virus. These structures and concepts for designing such vaccines are poised to move vaccine development beyond the current mRNA vaccines.

In addition, Mirkin invented dip-pen nanolithography, initially a technique for molecular writing with nanometer-scale precision that has evolved into a powerful platform for tip-based materials synthesis that, when combined with artificial intelligence, is revolutionizing how materials important for many sectors, especially clean energy, are discovered. Dip-pen nanolithography, which has spurred subsequent techniques that now use tens of millions of tiny tips to rapidly synthesize materials to be explored for such purposes, was recognized by National Geographic as one of the “top 100 scientific discoveries that changed the world.” These innovations are being commercialized by Mattiq, Inc., another venture-backed company Mirkin cofounded. Mirkin and his students also invented high-area rapid printing, an additive manufacturing technology, that is being commercialized by Azul 3D and being used to disrupt the microelectronics and optical lens industries.

Mirkin’s research has progressed SNA drugs through seven human clinical trials so far for treating various cancers, including glioblastoma multiforme and Merkel cell carcinoma. One SNA drug has shown remarkable potential in stimulating the immune system, proving effective in models of breast, colorectal and bladder cancers, lymphoma and melanoma. This drug has achieved complete tumor elimination in a subset of patients with Merkel cell carcinoma during Phase 1b/2 clinical trials, earning FDA fast-track and orphan drug status. It was recently licensed to Bluejay Therapeutics to treat hepatitis.

In 2000, Mirkin founded the International Institute for Nanotechnology (IIN) at Northwestern University, which he also directs. Research at the IIN has led to over 2,000 new commercial products sold globally and the creation of more than 40 startup companies. The IIN has collectively brought together over $1.2 billion to support research, education and infrastructure at Northwestern since its inception.

Mirkin is the George B. Rathmann Professor of Chemistry and a professor of medicine, chemical and biological engineering, biomedical engineering, and materials science and engineering at Northwestern. He is among an elite group of scientists elected to all three branches of the U.S. National Academies — the National Academy of Sciences, the National Academy of Engineering and the National Academy of Medicine. He is a member of the American Academy of Arts and Sciences. Mirkin served on President Obama’s Council of Advisors on Science and Technology for eight years.

Congratulations to all of the winners in all of the categories!

As for the Norway announcement, it makes a bit of sense given that Fred Kavli was a Norwegian American. However, it’s a little hard to avoid the suspicion that there might be some regional and prize rivalry between Norway with its Kavli and Sweden its Nobel..